CorMedix (NASDAQ:CRMD) Stock Price Up 5.9% Following Analyst Upgrade
CorMedix Inc. (NASDAQ:CRMD – Get Free Report)’s stock price rose 5.9% during mid-day trading on Thursday after Royal Bank of Canada raised their price target on the stock from $11.00 to $12.00. Royal Bank of Canada currently has an outperform rating on the stock. CorMedix traded as high as $8.75 and last traded at $8.60. […]
More Stories
DeFiChain (DFI) Trading 25% Lower Over Last 7 Days
DeFiChain (DFI) traded 5.8% higher against the US dollar during the 24-hour period ending at 10:00 AM ET on December...
UBS Group Issues Pessimistic Forecast for NIKE (NYSE:NKE) Stock Price
NIKE (NYSE:NKE – Get Free Report) had its target price reduced by equities research analysts at UBS Group from $80.00...
Centurion (CNT) Price Hits $0.0010
Centurion (CNT) traded 3% lower against the US dollar during the 24-hour period ending at 10:00 AM Eastern on December...
Stifel Nicolaus Forecasts Strong Price Appreciation for FactSet Research Systems (NYSE:FDS) Stock
FactSet Research Systems (NYSE:FDS – Get Free Report) had its price objective boosted by research analysts at Stifel Nicolaus from...
PotCoin (POT) Trading 37.3% Lower Over Last Week
PotCoin (POT) traded 22.1% lower against the dollar during the twenty-four hour period ending at 10:00 AM Eastern on December...
My DeFi Pet One Day Trading Volume Hits $41,393.20 (DPET)
My DeFi Pet (DPET) traded down 13.1% against the U.S. dollar during the 24 hour period ending at 10:00 AM...